Clinical Trial Update: Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias [Phase 2]

View source ↗

Summary

Phase 2 study results of bosutinib (SKI-606) in Japanese patients with Philadelphia chromosome-positive leukemias are reported, focusing on chronic myeloid leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• BOSULIF (bosutinib)

Snippet

Sponsor: Pfizer | Conditions: Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-06-04